Imricor Medical Systems, Inc. (IMR.AX)
AUD 1.19
(-8.46%)
AUD 1.19
(-8.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.46 Million AUD | 8.23% |
| 2022 | 2.27 Million USD | -11.85% |
| 2021 | 2.58 Million AUD | -15.87% |
| 2020 | 3.06 Million AUD | 151.51% |
| 2019 | 1.22 Million AUD | 226.37% |
| 2018 | 374 Thousand AUD | 97.76% |
| 2017 | 189.12 Thousand AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.85 Million USD | 0.0% |
| 2024 Q1 | 1.85 Million USD | 10.61% |
| 2023 Q1 | 2.22 Million USD | -2.12% |
| 2023 FY | 2.46 Million AUD | 8.23% |
| 2023 Q3 | 1.68 Million USD | -24.55% |
| 2023 Q2 | 2.22 Million USD | 0.0% |
| 2023 Q4 | 1.68 Million USD | 0.0% |
| 2022 Q4 | 2.27 Million USD | 0.0% |
| 2022 FY | 2.27 Million USD | -11.85% |
| 2022 Q3 | 2.27 Million USD | -2.18% |
| 2022 Q1 | 2.32 Million USD | -9.88% |
| 2022 Q2 | 2.32 Million USD | 0.0% |
| 2021 Q3 | 2.58 Million USD | -8.5% |
| 2021 FY | 2.58 Million AUD | -15.87% |
| 2021 Q1 | 2.82 Million USD | -29.18% |
| 2021 Q4 | 2.58 Million AUD | 0.0% |
| 2021 Q2 | 2.82 Million USD | 0.0% |
| 2020 Q4 | 3.98 Million AUD | 29.84% |
| 2020 FY | 3.06 Million AUD | 151.51% |
| 2020 Q1 | 2.26 Million USD | 85.44% |
| 2020 Q2 | 2.26 Million USD | 0.0% |
| 2020 Q3 | 3.06 Million USD | 35.62% |
| 2019 Q4 | 1.22 Million USD | 0.0% |
| 2019 FY | 1.22 Million AUD | 226.37% |
| 2019 Q3 | 1.22 Million USD | 127.51% |
| 2019 Q2 | 536.51 Thousand USD | 0.0% |
| 2019 Q1 | 536.51 Thousand USD | 43.33% |
| 2018 FY | 374 Thousand AUD | 97.76% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 374.31 Thousand USD | 0.0% |
| 2018 Q4 | 374.31 Thousand USD | 0.0% |
| 2017 FY | 189.12 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| 4DMedical Limited | 992.24 Thousand AUD | -148.331% |
| Adherium Limited | 1.58 Million AUD | -55.727% |
| Aroa Biosurgery Limited | 7.43 Million AUD | 66.837% |
| Atomo Diagnostics Limited | 1.83 Million AUD | -34.007% |
| Anteris Technologies Ltd | 646.71 Thousand AUD | -281.014% |
| Control Bionics Limited | 404.15 Thousand AUD | -509.69% |
| CardieX Limited | 2.55 Million AUD | 3.503% |
| Compumedics Limited | 13.21 Million AUD | 81.348% |
| Cochlear Limited | 391.6 Million AUD | 99.371% |
| CleanSpace Holdings Limited | 2.86 Million AUD | 14.009% |
| Cyclopharm Limited | 10.12 Million AUD | 75.656% |
| EMVision Medical Devices Ltd | - AUD | -Infinity% |
| Nova Eye Medical Limited | 4.28 Million AUD | 42.469% |
| HeraMED Limited | 361.61 Thousand AUD | -581.411% |
| ImpediMed Limited | 759 Thousand AUD | -224.646% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.61 Million AUD | -52.291% |
| Micro-X Limited | 5.37 Million AUD | 54.191% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 391.67 Thousand AUD | -529.116% |
| PolyNovo Limited | 8.97 Million AUD | 72.536% |
| Respiri Limited | 2.75 Million AUD | 10.449% |
| SomnoMed Limited | 6.28 Million AUD | 60.797% |
| Universal Biosensors, Inc. | 4.37 Million AUD | 43.716% |
| Uscom Limited | 623.62 Thousand AUD | -295.119% |
| Visioneering Technologies, Inc. | 3.16 Million AUD | 22.196% |